Células madre mesenquimales: Estrategia inmunomoduladora de vanguardia en el tratamiento de las complicaciones por COVID-19

Villatoro Jiménez, Antonio J; Fariñas Guerrero, Fernando.
Inmunología (1987) ; 40(1): 27-30, ene.-mar. 2021. ilus
Artículo en Español | IBECS (España) | ID: ibc-222145

Documentos relacionados

  1. [Living with an ongoing crisis - insights from the coronavirus - SARS-CoV].
  2. Coronavirus: time to re-imagine academic publishing.
  3. Nytt koronavirus: Tiden er inne til å ta drastiske grep.
  4. CRISPR tool scales up to interrogate a huge line-up of viral suspects.
  5. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
  6. [Structure of SARS-CoV-2 and treatment of COVID-19].
  7. SARS-CoV-2: characteristics and current advances in research.
  8. SARS-CoV-2: Combating Coronavirus Emergence.
  9. Management of post-mortem examination in SARS-CoV-19 infections.
  10. Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective.